Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-068446
Filing Date
2020-06-01
Accepted
2020-06-01 17:00:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm2021447-1_sc13g.htm SC 13G 60943
  Complete submission text file 0001104659-20-068446.txt   62458
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Subject) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88903 | Film No.: 20934130
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 WALL STREET BURLINGTON MA 01803
Business Address 1 WALL STREET BURLINGTON MA 01803 781-652-7800
SEKISUI DIAGNOSTICS, LLC (Filed by) CIK: 0001812012 (see all company filings)

EIN.: 274058664
Type: SC 13G